Direct Somatic Cell Transdifferentiation Using GLIS Genes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing somatic cells, such as adipocytes, neuronal cells, cardiomyocytes, and hepatocytes, face challenges with complexity, low reproducibility, inefficiency, and long production times, making them unsuitable for large-scale applications in regenerative medicine and disease screening.
Innovation Solution
A method involving the introduction of a GLIS family gene, optionally with a mutated form and a transcription factor, into somatic cells, followed by culturing in a medium containing growth factors and differentiation-inducing components to directly transdifferentiate these cells into desired somatic cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If embryonic stem cells or induced pluripotent stem cells are used to produce somatic cells, then the production of somatic cells can be achieved, but the process becomes complicated requiring various inhibitors and takes at least 21 to 30 days
Solution Approach 1:
The invention extracts and eliminates the unnecessary stem cell stage from the traditional differentiation process. By directly transdifferentiating somatic cells into target somatic cells through gene introduction and specific culture conditions, the method removes the complex stem cell culture environment requirements and significantly shortens production time from 21-30 days to a much shorter period.
Solution Approach 2:
The invention skips the intermediate stem cell stage entirely in the cell production process. By implementing direct transdifferentiation where somatic cells are converted directly into target somatic cells through genetic modification and controlled culture, the method rushes through the traditional multi-stage process, eliminating time-consuming intermediate steps while reducing cultural environment complexity.
2Reliability
If traditional differentiation methods are used with stem cells, then somatic cells can be produced, but reproducibility cannot be obtained
Solution Approach 1:
The invention changes the fundamental parameters of the cell production process by using direct transdifferentiation instead of stem cell differentiation. This involves introducing specific genes (such as GLIS1 and neurogenin 3) and controlling culture conditions to achieve consistent, reproducible results. The direct conversion process with defined genetic and cultural parameters eliminates the variability associated with complex stem cell culture environments.
3Productivity
If stem cell-based methods are used, then somatic cells can be produced, but cells other than the desired somatic cells are also produced reducing efficiency
Solution Approach 1:
The invention applies local quality by targeting specific gene introduction and culture conditions that direct only the desired transdifferentiation pathway. By introducing specific transcription factors and controlling the cultural environment to match the target cell type requirements, the method ensures that only the desired somatic cells are produced with high purity, eliminating the production of unwanted cell types that occurs in stem cell-based methods.
Data Source
AI summary
A method of direct transdifferentiation of somatic cells into other somatic cells may be convenient and still have good reproducibility, excellent production efficiency, and short performed time. Methods for direct transdifferentiation of somatic cells into other somatic cells may include: (a) introducing a GLIS family gene, a mutated GLIS family gene or a gene product thereof into somatic cells; and (b) culturing the gene-introduced somatic cells in a culture medium containing a component that induces differentiation of the somatic cells or precursor cells of the somatic cells into other somatic cells.